Insider Transactions in Q2 2022 at Greenwich Life Sciences, Inc. (GLSI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Indirect |
6,465
+0.24%
|
$58,185
$9.13 P/Share
|
|
Jun 24
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
22,535
+0.83%
|
$202,815
$9.13 P/Share
|
|
Jun 16
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
8,000
+0.3%
|
$56,000
$7.13 P/Share
|
|
Jun 14
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
12,000
+0.45%
|
$84,000
$7.91 P/Share
|
|
Jun 10
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
12,000
+0.45%
|
$96,000
$8.33 P/Share
|
|
Jun 09
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
4,500
+0.36%
|
$45,000
$10.9 P/Share
|
|
Jun 07
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
6,000
+0.48%
|
$48,000
$8.55 P/Share
|
|
Jun 03
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
9,250
+0.74%
|
$74,000
$8.35 P/Share
|
|
Jun 02
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
6,774
+0.55%
|
$47,418
$7.38 P/Share
|
|
Apr 25
2022
|
Frank Joseph Daugherty Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.1%
|
$16,000
$16.25 P/Share
|
|
Apr 21
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
6,000
+0.49%
|
$96,000
$16.09 P/Share
|
|
Apr 19
2022
|
Snehal Patel CEO and CFO |
BUY
Open market or private purchase
|
Direct |
6,000
+0.49%
|
$96,000
$16.74 P/Share
|
|
Apr 19
2022
|
Jaye Thompson VP Clinical Reg Affairs |
BUY
Open market or private purchase
|
Direct |
500
+0.19%
|
$8,000
$16.74 P/Share
|